secondary amino compound - Ontology Report

Help | FTP Download | Citing RGD | Contact Us

Keyword

ONTOLOGY REPORT - ANNOTATIONS

Term:	secondary amino compound	go back to main search page
Accession:	CHEBI:50995	browse the term
Definition:	A compound formally derived from ammonia by replacing two hydrogen atoms by organyl groups.
Synonyms:	related_synonym:	secondary amino compounds

Rat
Mouse
Human
All
show annotations for term's descendants
Sort by:

acebutolol
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		increases activity	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		increases expression	ISO	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	ISO	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	ISO	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Ren	renin		decreases activity	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		decreases activity	EXP	13	46,262,936	46,275,213	RGD:6480464	CTD
albuterol
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	EXP	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		decreases response to substance	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		increases phosphorylation	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		decreases expression	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	EXP	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	EXP	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		increases phosphorylation	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb3	adrenoceptor beta 3		multiple interactions	ISO	16	69,163,620	69,166,384	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		increases expression	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		decreases expression	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Cat	catalase		multiple interactions	ISO	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Ccl3	chemokine (C-C motif) ligand 3		multiple interactions	ISO	10	71,744,559	71,746,109	RGD:6480464	CTD
G	Ccl5	chemokine (C-C motif) ligand 5		multiple interactions	ISO	10	71,605,791	71,610,330	RGD:6480464	CTD
G	Cdk2	cyclin dependent kinase 2		increases expression	ISO	7	2,000,196	2,007,682	RGD:6480464	CTD
G	Cdk4	cyclin-dependent kinase 4		increases expression	ISO				RGD:6480464	CTD
G	Ckm	creatine kinase, muscle		increases secretion	ISO	1	78,762,202	78,772,681	RGD:6480464	CTD
G	Csf2	colony stimulating factor 2 (granulocyte-macrophage)		multiple interactions	ISO	10	39,665,850	39,667,831	RGD:6480464	CTD
G	Cyp17a1	cytochrome P450, family 17, subfamily a, polypeptide 1		increases expression	ISO	1	251,965,458	251,971,449	RGD:6480464	CTD
G	Cyp19a1	cytochrome P450, family 19, subfamily a, polypeptide 1		multiple interactions	ISO				RGD:6480464	CTD
G	G6pd	glucose-6-phosphate dehydrogenase		increases activity	EXP	X	160,186,450	160,192,316	RGD:6480464	CTD
G	Il10	interleukin 10		decreases expression	EXP	13	43,953,900	43,957,766	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		multiple interactions	ISO	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il5	interleukin 5		multiple interactions	ISO	10	39,177,786	39,180,657	RGD:6480464	CTD
G	Il6	interleukin 6		increases expression	ISO	4	456,799	461,376	RGD:6480464	CTD
G	Il6	interleukin 6		multiple interactions	ISO	4	456,799	461,376	RGD:6480464	CTD
G	Il6	interleukin 6		multiple interactions	EXP	4	456,799	461,376	RGD:6480464	CTD
G	Ins2	insulin 2		increases expression	ISO	1	202,935,548	202,936,379	RGD:6480464	CTD
G	Ins2	insulin 2		increases expression	ISO	1	202,935,548	202,936,379	RGD:6480464	CTD
G	Ldlr	low density lipoprotein receptor		affects response to substance	ISO	8	20,824,040	20,846,920	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	ISO	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	EXP	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	ISO	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	EXP	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mpo	myeloperoxidase		multiple interactions	ISO	10	76,085,872	76,097,012	RGD:6480464	CTD
G	Nfkbia	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha		increases expression	ISO	6	75,729,302	75,732,475	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		multiple interactions	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nr3c1	nuclear receptor subfamily 3, group C, member 1		multiple interactions	ISO	18	32,371,496	32,459,145	RGD:6480464	CTD
G	Pde4a	phosphodiesterase 4A, cAMP-specific		multiple interactions	ISO	8	20,192,677	20,241,557	RGD:6480464	CTD
G	Pde4b	phosphodiesterase 4B, cAMP specific		multiple interactions	ISO	5	123,158,156	123,533,877	RGD:6480464	CTD
G	Ppargc1a	peroxisome proliferator-activated receptor gamma, coactivator 1 alpha		increases expression	ISO	14	64,278,115	64,370,912	RGD:6480464	CTD
G	Ptafr	platelet-activating factor receptor		increases expression	ISO	5	152,565,687	152,587,342	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		multiple interactions	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Rb1	retinoblastoma 1		decreases expression	ISO	15	53,828,881	53,962,099	RGD:6480464	CTD
G	Rb1	retinoblastoma 1		increases expression	ISO	15	53,828,881	53,962,099	RGD:6480464	CTD
G	Rb1	retinoblastoma 1		multiple interactions	ISO	15	53,828,881	53,962,099	RGD:6480464	CTD
G	Ren	renin		increases expression	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		decreases secretion	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tp53	tumor protein p53		increases expression	ISO	10	56,399,721	56,411,150	RGD:6480464	CTD
G	Ucp1	uncoupling protein 1 (mitochondrial, proton carrier)		increases expression	ISO	19	26,527,548	26,535,621	RGD:6480464	CTD
G	Ucp3	uncoupling protein 3 (mitochondrial, proton carrier)		multiple interactions	ISO	1	157,896,001	157,909,608	RGD:6480464	CTD
atomoxetine
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cyp2d3	cytochrome P450, family 2, subfamily d, polypeptide 3		increases hydroxylation	ISO	7	120,778,783	120,783,140	RGD:6480464	CTD
G	Cyp2d4	cytochrome P450, family 2, subfamily d, polypeptide 4		increases hydroxylation	ISO	7	120,742,273	120,752,274	RGD:6480464	CTD
bisoprolol
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Abcb1a	ATP-binding cassette, sub-family B (MDR/TAP), member 1A		increases transport	ISO	4	21,709,855	21,796,628	RGD:6480464	CTD
G	Abcb1a	ATP-binding cassette, sub-family B (MDR/TAP), member 1A		multiple interactions	ISO	4	21,709,855	21,796,628	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		increases expression	EXP	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		affects binding	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		decreases activity	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	EXP	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		increases expression	EXP	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb3	adrenoceptor beta 3		multiple interactions	ISO	16	69,163,620	69,166,384	RGD:6480464	CTD
G	Ccl2	chemokine (C-C motif) ligand 2		decreases expression	ISO	10	70,256,263	70,258,061	RGD:6480464	CTD
G	Gnas	GNAS complex locus		increases expression	EXP	3	165,213,399	165,214,551	RGD:6480464	CTD
G	Il10	interleukin 10		increases expression	ISO	13	43,953,900	43,957,766	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		decreases expression	ISO	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il6	interleukin 6		decreases expression	ISO	4	456,799	461,376	RGD:6480464	CTD
G	Ins2	insulin 2		multiple interactions	ISO	1	202,935,548	202,936,379	RGD:6480464	CTD
G	Prkca	protein kinase C, alpha		decreases expression	EXP	10	97,367,196	97,638,910	RGD:6480464	CTD
G	Prkcd	protein kinase C, delta		decreases expression	EXP	16	5,954,218	5,975,743	RGD:6480464	CTD
G	Slc22a1	solute carrier family 22 (organic cation transporter), member 1		multiple interactions	ISO	1	42,351,239	42,378,295	RGD:6480464	CTD
G	Slc22a2	solute carrier family 22 (organic cation transporter), member 2		multiple interactions	ISO	1	42,395,676	42,442,847	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		decreases expression	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
brimonidine
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Adra2a	adrenoceptor alpha 2A		multiple interactions	ISO				RGD:6480464	CTD
G	Adra2a	adrenoceptor alpha 2A		multiple interactions	ISO				RGD:6480464	CTD
G	Adra2a	adrenoceptor alpha 2A		multiple interactions	EXP				RGD:6480464	CTD
G	Adra2a	adrenoceptor alpha 2A		multiple interactions	EXP				RGD:6480464	CTD
G	Adra2a	adrenoceptor alpha 2A		multiple interactions	EXP				RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		multiple interactions	EXP	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Cftr	cystic fibrosis transmembrane conductance regulator		multiple interactions	ISO	4	43,874,852	44,041,870	RGD:6480464	CTD
G	Prkca	protein kinase C, alpha		affects localization	EXP	10	97,367,196	97,638,910	RGD:6480464	CTD
G	Prkca	protein kinase C, alpha		multiple interactions	EXP	10	97,367,196	97,638,910	RGD:6480464	CTD
G	Prkcd	protein kinase C, delta		affects localization	EXP	16	5,954,218	5,975,743	RGD:6480464	CTD
G	Prkcd	protein kinase C, delta		multiple interactions	EXP	16	5,954,218	5,975,743	RGD:6480464	CTD
G	Rhoa	ras homolog family member A		multiple interactions	EXP				RGD:6480464	CTD
carvedilol
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Abcb1a	ATP-binding cassette, sub-family B (MDR/TAP), member 1A		multiple interactions	ISO	4	21,709,855	21,796,628	RGD:6480464	CTD
G	Ace	angiotensin I converting enzyme (peptidyl-dipeptidase A) 1		multiple interactions	EXP	10	95,361,338	95,381,455	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		affects response to substance	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		affects response to substance	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		affects binding	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		affects response to substance	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	EXP	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		increases expression	EXP	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		affects binding	EXP	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		increases phosphorylation	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb3	adrenoceptor beta 3		multiple interactions	ISO	16	69,163,620	69,166,384	RGD:6480464	CTD
G	Adrb3	adrenoceptor beta 3		affects response to substance	ISO	16	69,163,620	69,166,384	RGD:6480464	CTD
G	Adrb3	adrenoceptor beta 3		decreases expression	EXP	16	69,163,620	69,166,384	RGD:6480464	CTD
G	Adrbk1	adrenergic, beta, receptor kinase 1		multiple interactions	ISO	1	206,873,002	206,892,868	RGD:6480464	CTD
G	Adrbk1	adrenergic, beta, receptor kinase 1		multiple interactions	ISO	1	206,873,002	206,892,868	RGD:6480464	CTD
G	Adrbk1	adrenergic, beta, receptor kinase 1		increases expression	ISO	1	206,873,002	206,892,868	RGD:6480464	CTD
G	Adrbk1	adrenergic, beta, receptor kinase 1		decreases expression	ISO	1	206,873,002	206,892,868	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		multiple interactions	EXP	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		multiple interactions	EXP	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		decreases expression	ISO	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		decreases response to substance	EXP	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		decreases response to substance	EXP	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		multiple interactions	ISO	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		multiple interactions	EXP	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		decreases response to substance	EXP	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		multiple interactions	EXP	19	54,738,556	54,750,349	RGD:6480464	CTD
G	App	amyloid beta (A4) precursor protein		decreases expression	ISO	11	24,457,855	24,693,851	RGD:6480464	CTD
G	Arrb1	arrestin, beta 1		multiple interactions	ISO	1	156,871,564	156,937,540	RGD:6480464	CTD
G	Arrb2	arrestin, beta 2		multiple interactions	ISO	10	57,244,071	57,284,166	RGD:6480464	CTD
G	Arrb2	arrestin, beta 2		multiple interactions	ISO	10	57,244,071	57,284,166	RGD:6480464	CTD
G	Arrb2	arrestin, beta 2		affects localization	EXP	10	57,244,071	57,284,166	RGD:6480464	CTD
G	Arrb2	arrestin, beta 2		multiple interactions	EXP	10	57,244,071	57,284,166	RGD:6480464	CTD
G	Atp2a2	ATPase, Ca++ transporting, cardiac muscle, slow twitch 2		multiple interactions	EXP	12	35,266,600	35,316,237	RGD:6480464	CTD
G	Atp2a2	ATPase, Ca++ transporting, cardiac muscle, slow twitch 2		increases expression	EXP	12	35,266,600	35,316,237	RGD:6480464	CTD
G	Atp2a2	ATPase, Ca++ transporting, cardiac muscle, slow twitch 2		increases expression	EXP	12	35,266,600	35,316,237	RGD:6480464	CTD
G	Atp2a2	ATPase, Ca++ transporting, cardiac muscle, slow twitch 2		increases expression	EXP	12	35,266,600	35,316,237	RGD:6480464	CTD
G	Avp	arginine vasopressin		decreases expression	ISO	3	118,205,007	118,206,985	RGD:6480464	CTD
G	Avp	arginine vasopressin		multiple interactions	EXP	3	118,205,007	118,206,985	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		multiple interactions	EXP	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		decreases expression	EXP	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		increases expression	EXP	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		multiple interactions	EXP	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		increases expression	EXP	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		affects expression	EXP	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		increases expression	EXP	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2l1	Bcl2-like 1		increases expression	EXP	3	143,129,087	143,180,199	RGD:6480464	CTD
G	Becn1	beclin 1, autophagy related		increases expression	EXP	10	90,317,957	90,333,329	RGD:6480464	CTD
G	Calca	calcitonin-related polypeptide alpha		multiple interactions	EXP	1	172,686,168	172,691,061	RGD:6480464	CTD
G	Calcb	calcitonin-related polypeptide, beta		multiple interactions	EXP	1	172,777,347	172,781,003	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	EXP	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	EXP	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Cat	catalase		multiple interactions	EXP	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cat	catalase		increases activity	EXP	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cfl1	cofilin 1, non-muscle		decreases expression	EXP	1	208,133,876	208,137,408	RGD:6480464	CTD
G	Col1a1	collagen, type I, alpha 1		multiple interactions	EXP	10	83,622,438	83,639,368	RGD:6480464	CTD
G	Col1a1	collagen, type I, alpha 1		multiple interactions	EXP	10	83,622,438	83,639,368	RGD:6480464	CTD
G	Col1a1	collagen, type I, alpha 1		multiple interactions	EXP	10	83,622,438	83,639,368	RGD:6480464	CTD
G	Col1a1	collagen, type I, alpha 1		multiple interactions	EXP	10	83,622,438	83,639,368	RGD:6480464	CTD
G	Col1a1	collagen, type I, alpha 1		multiple interactions	EXP	10	83,622,438	83,639,368	RGD:6480464	CTD
G	Col1a1	collagen, type I, alpha 1		decreases expression	EXP	10	83,622,438	83,639,368	RGD:6480464	CTD
G	Col1a1	collagen, type I, alpha 1		decreases expression	EXP	10	83,622,438	83,639,368	RGD:6480464	CTD
G	Crp	C-reactive protein, pentraxin-related		decreases expression	ISO	13	88,702,243	88,703,153	RGD:6480464	CTD
G	Csf2	colony stimulating factor 2 (granulocyte-macrophage)		multiple interactions	ISO	10	39,665,850	39,667,831	RGD:6480464	CTD
G	Cycs	cytochrome c, somatic		increases expression	EXP	4	78,825,878	78,827,978	RGD:6480464	CTD
G	Cyp2d3	cytochrome P450, family 2, subfamily d, polypeptide 3		affects glucuronidation	ISO	7	120,778,783	120,783,140	RGD:6480464	CTD
G	Cyp2d4	cytochrome P450, family 2, subfamily d, polypeptide 4		affects metabolic processing	ISO	7	120,742,273	120,752,274	RGD:6480464	CTD
G	Cyp2d4	cytochrome P450, family 2, subfamily d, polypeptide 4		affects metabolic processing	ISO	7	120,742,273	120,752,274	RGD:6480464	CTD
G	Cyp2d4	cytochrome P450, family 2, subfamily d, polypeptide 4		affects metabolic processing	ISO	7	120,742,273	120,752,274	RGD:6480464	CTD
G	Cyp2d4	cytochrome P450, family 2, subfamily d, polypeptide 4		affects glucuronidation	ISO	7	120,742,273	120,752,274	RGD:6480464	CTD
G	Cyp2d4	cytochrome P450, family 2, subfamily d, polypeptide 4		affects metabolic processing	ISO	7	120,742,273	120,752,274	RGD:6480464	CTD
G	Edn1	endothelin 1		decreases secretion	ISO	17	28,303,886	28,309,775	RGD:6480464	CTD
G	Fas	Fas (TNF receptor superfamily, member 6)		multiple interactions	ISO	1	238,259,443	238,274,745	RGD:6480464	CTD
G	Faslg	Fas ligand (TNF superfamily, member 6)		multiple interactions	ISO	13	77,472,950	77,480,210	RGD:6480464	CTD
G	Gja1	gap junction protein, alpha 1		increases expression	ISO	20	35,409,815	35,422,262	RGD:6480464	CTD
G	Gja1	gap junction protein, alpha 1		decreases degradation	ISO	20	35,409,815	35,422,262	RGD:6480464	CTD
G	Gja1	gap junction protein, alpha 1		increases expression	EXP	20	35,409,815	35,422,262	RGD:6480464	CTD
G	Gja1	gap junction protein, alpha 1		increases expression	EXP	20	35,409,815	35,422,262	RGD:6480464	CTD
G	Gja1	gap junction protein, alpha 1		increases expression	EXP	20	35,409,815	35,422,262	RGD:6480464	CTD
G	Gja4	gap junction protein, alpha 4		increases expression	EXP	5	146,755,061	146,757,594	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		increases expression	ISO	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		increases expression	ISO	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Il10	interleukin 10		multiple interactions	ISO	13	43,953,900	43,957,766	RGD:6480464	CTD
G	Il10	interleukin 10		increases expression	ISO	13	43,953,900	43,957,766	RGD:6480464	CTD
G	Il10	interleukin 10		increases expression	EXP	13	43,953,900	43,957,766	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		decreases expression	ISO	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		decreases expression	EXP	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		multiple interactions	ISO	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il6	interleukin 6		multiple interactions	EXP	4	456,799	461,376	RGD:6480464	CTD
G	Il6	interleukin 6		multiple interactions	EXP	4	456,799	461,376	RGD:6480464	CTD
G	Ins2	insulin 2		decreases expression	ISO	1	202,935,548	202,936,379	RGD:6480464	CTD
G	Kcnh2	potassium voltage-gated channel, subfamily H (eag-related), member 2		decreases activity	ISO	4	6,192,644	6,224,285	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	EXP	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk14	mitogen activated protein kinase 14		multiple interactions	EXP	20	6,939,249	7,000,378	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	EXP	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mmp2	matrix metallopeptidase 2		multiple interactions	EXP	19	15,246,036	15,275,061	RGD:6480464	CTD
G	Mmp2	matrix metallopeptidase 2		decreases expression	EXP	19	15,246,036	15,275,061	RGD:6480464	CTD
G	Mmp8	matrix metallopeptidase 8		decreases expression	ISO	8	4,402,124	4,410,976	RGD:6480464	CTD
G	Mmp9	matrix metallopeptidase 9		affects activity	ISO	3	155,985,473	155,993,433	RGD:6480464	CTD
G	Mmp9	matrix metallopeptidase 9		multiple interactions	EXP	3	155,985,473	155,993,433	RGD:6480464	CTD
G	Mmp9	matrix metallopeptidase 9		decreases expression	EXP	3	155,985,473	155,993,433	RGD:6480464	CTD
G	Mpo	myeloperoxidase		multiple interactions	ISO	10	76,085,872	76,097,012	RGD:6480464	CTD
G	Mpo	myeloperoxidase		multiple interactions	ISO	10	76,085,872	76,097,012	RGD:6480464	CTD
G	Mpo	myeloperoxidase		multiple interactions	ISO	10	76,085,872	76,097,012	RGD:6480464	CTD
G	Mpo	myeloperoxidase		multiple interactions	ISO	10	76,085,872	76,097,012	RGD:6480464	CTD
G	Msn	moesin		decreases expression	EXP	X	83,716,068	83,784,214	RGD:6480464	CTD
G	Mstn	myostatin		decreases expression	EXP	9	45,426,831	45,431,658	RGD:6480464	CTD
G	Myc	myelocytomatosis oncogene		decreases expression	EXP	7	98,953,142	98,958,060	RGD:6480464	CTD
G	Myc	myelocytomatosis oncogene		affects expression	EXP	7	98,953,142	98,958,060	RGD:6480464	CTD
G	Myl12a	myosin, light chain 12A, regulatory, non-sarcomeric		decreases expression	EXP	9	110,190,030	110,197,715	RGD:6480464	CTD
G	Nfatc4	nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4		increases phosphorylation	EXP	15	33,969,774	33,978,848	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		multiple interactions	ISO	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		multiple interactions	ISO	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos3	nitric oxide synthase 3, endothelial cell		increases expression	EXP	4	6,158,847	6,179,441	RGD:6480464	CTD
G	Nos3	nitric oxide synthase 3, endothelial cell		increases expression	EXP	4	6,158,847	6,179,441	RGD:6480464	CTD
G	Nos3	nitric oxide synthase 3, endothelial cell		decreases expression	EXP	4	6,158,847	6,179,441	RGD:6480464	CTD
G	Nos3	nitric oxide synthase 3, endothelial cell		increases expression	EXP	4	6,158,847	6,179,441	RGD:6480464	CTD
G	Nos3	nitric oxide synthase 3, endothelial cell		increases phosphorylation	EXP	4	6,158,847	6,179,441	RGD:6480464	CTD
G	Nox1	NADPH oxidase 1		multiple interactions	EXP				RGD:6480464	CTD
G	Nphs1	nephrosis 1, congenital, Finnish type (nephrin)		increases expression	EXP	1	85,414,492	85,444,233	RGD:6480464	CTD
G	Nppa	natriuretic peptide A		increases expression	EXP	5	165,074,518	165,075,827	RGD:6480464	CTD
G	Nppa	natriuretic peptide A		decreases expression	ISO	5	165,074,518	165,075,827	RGD:6480464	CTD
G	Nppa	natriuretic peptide A		multiple interactions	EXP	5	165,074,518	165,075,827	RGD:6480464	CTD
G	Nppa	natriuretic peptide A		decreases degradation	EXP	5	165,074,518	165,075,827	RGD:6480464	CTD
G	Nppa	natriuretic peptide A		multiple interactions	EXP	5	165,074,518	165,075,827	RGD:6480464	CTD
G	Nppa	natriuretic peptide A		decreases expression	EXP	5	165,074,518	165,075,827	RGD:6480464	CTD
G	Nppa	natriuretic peptide A		increases expression	EXP	5	165,074,518	165,075,827	RGD:6480464	CTD
G	Nppa	natriuretic peptide A		increases expression	EXP	5	165,074,518	165,075,827	RGD:6480464	CTD
G	Nppb	natriuretic peptide B		decreases expression	ISO	5	165,062,348	165,063,650	RGD:6480464	CTD
G	Nppb	natriuretic peptide B		decreases expression	EXP	5	165,062,348	165,063,650	RGD:6480464	CTD
G	Nppb	natriuretic peptide B		multiple interactions	ISO	5	165,062,348	165,063,650	RGD:6480464	CTD
G	Nppb	natriuretic peptide B		decreases expression	EXP	5	165,062,348	165,063,650	RGD:6480464	CTD
G	Nppb	natriuretic peptide B		decreases expression	EXP	5	165,062,348	165,063,650	RGD:6480464	CTD
G	Nppb	natriuretic peptide B		increases expression	EXP	5	165,062,348	165,063,650	RGD:6480464	CTD
G	Nppb	natriuretic peptide B		decreases expression	ISO	5	165,062,348	165,063,650	RGD:6480464	CTD
G	Npr3	natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C)		decreases expression	EXP	2	61,278,264	61,341,460	RGD:6480464	CTD
G	Npr3	natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C)		decreases expression	EXP	2	61,278,264	61,341,460	RGD:6480464	CTD
G	Olr1	oxidized low density lipoprotein (lectin-like) receptor 1		multiple interactions	EXP	4	166,747,228	166,769,340	RGD:6480464	CTD
G	Pdgfb	platelet-derived growth factor beta polypeptide		multiple interactions	ISO	7	118,244,385	118,262,021	RGD:6480464	CTD
G	Pgd	phosphogluconate dehydrogenase		multiple interactions	EXP				RGD:6480464	CTD
G	Ppara	peroxisome proliferator activated receptor alpha		multiple interactions	EXP	7	123,729,774	123,807,090	RGD:6480464	CTD
G	Ppargc1a	peroxisome proliferator-activated receptor gamma, coactivator 1 alpha		increases expression	EXP	14	64,278,115	64,370,912	RGD:6480464	CTD
G	Prkca	protein kinase C, alpha		decreases expression	EXP	10	97,367,196	97,638,910	RGD:6480464	CTD
G	Prkcd	protein kinase C, delta		decreases expression	EXP	16	5,954,218	5,975,743	RGD:6480464	CTD
G	Prkce	protein kinase C, epsilon		increases activity	EXP	6	9,631,234	10,097,311	RGD:6480464	CTD
G	Rac1	ras-related C3 botulinum toxin substrate 1		multiple interactions	EXP	12	11,380,314	11,400,531	RGD:6480464	CTD
G	Ren	renin		decreases expression	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ryr2	ryanodine receptor 2, cardiac		affects activity	ISO	17	68,959,042	69,544,816	RGD:6480464	CTD
G	Ryr2	ryanodine receptor 2, cardiac		multiple interactions	ISO	17	68,959,042	69,544,816	RGD:6480464	CTD
G	Slc22a3	solute carrier family 22 (extraneuronal monoamine transporter), member 3		multiple interactions	ISO	1	42,690,158	42,781,895	RGD:6480464	CTD
G	Tgfb1	transforming growth factor, beta 1		decreases expression	ISO	1	80,894,705	80,911,020	RGD:6480464	CTD
G	Tgfb1	transforming growth factor, beta 1		decreases expression	ISO	1	80,894,705	80,911,020	RGD:6480464	CTD
G	Tgfb1	transforming growth factor, beta 1		decreases expression	EXP	1	80,894,705	80,911,020	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		decreases expression	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Ugt1a1	UDP glucuronosyltransferase 1 family, polypeptide A1		increases glucuronidation	ISO	9	87,091,241	87,098,362	RGD:6480464	CTD
G	Ugt2b17	UDP glucuronosyltransferase 2 family, polypeptide B17		increases glucuronidation	ISO	14	22,639,182	22,650,931	RGD:6480464	CTD
G	Ugt2b7	UDP glucuronosyltransferase 2 family, polypeptide B7		increases glucuronidation	ISO	14	22,499,152	22,522,842	RGD:6480464	CTD
clenbuterol
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Acadm	acyl-CoA dehydrogenase, C-4 to C-12 straight chain		increases expression	ISO	2	251,866,645	251,890,729	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	EXP	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb3	adrenoceptor beta 3		multiple interactions	EXP	16	69,163,620	69,166,384	RGD:6480464	CTD
G	Akt1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	EXP	6	137,640,482	137,657,552	RGD:6480464	CTD
G	Akt2	v-akt murine thymoma viral oncogene homolog 2		multiple interactions	EXP	1	82,686,233	82,726,544	RGD:6480464	CTD
G	Akt3	v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma)		multiple interactions	EXP	13	92,802,390	93,110,704	RGD:6480464	CTD
G	Cyp1a1	cytochrome P450, family 1, subfamily a, polypeptide 1		multiple interactions	EXP	8	61,462,207	61,468,237	RGD:6480464	CTD
G	Cyp1a2	cytochrome P450, family 1, subfamily a, polypeptide 2		multiple interactions	EXP	8	61,439,062	61,447,861	RGD:6480464	CTD
G	Esrra	estrogen related receptor, alpha		increases expression	ISO	1	209,587,681	209,597,677	RGD:6480464	CTD
G	Gad1	glutamate decarboxylase 1		multiple interactions	EXP	3	52,789,370	52,830,038	RGD:6480464	CTD
G	Il10	interleukin 10		multiple interactions	ISO	13	43,953,900	43,957,766	RGD:6480464	CTD
G	Il10	interleukin 10		affects expression	EXP	13	43,953,900	43,957,766	RGD:6480464	CTD
G	Il18	interleukin 18		increases expression	ISO	8	53,936,584	53,943,228	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		multiple interactions	EXP	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il6	interleukin 6		multiple interactions	EXP	4	456,799	461,376	RGD:6480464	CTD
G	Nfkbia	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha		multiple interactions	ISO	6	75,729,302	75,732,475	RGD:6480464	CTD
G	Odc1	ornithine decarboxylase 1		multiple interactions	ISO	6	41,309,211	41,315,796	RGD:6480464	CTD
G	Odc1	ornithine decarboxylase 1		increases activity	ISO	6	41,309,211	41,315,796	RGD:6480464	CTD
G	Odc1	ornithine decarboxylase 1		increases stability	ISO	6	41,309,211	41,315,796	RGD:6480464	CTD
G	Pdk4	pyruvate dehydrogenase kinase, isozyme 4		increases expression	ISO	4	30,235,296	30,245,298	RGD:6480464	CTD
G	Ppargc1a	peroxisome proliferator-activated receptor gamma, coactivator 1 alpha		increases expression	ISO	14	64,278,115	64,370,912	RGD:6480464	CTD
G	Ppargc1a	peroxisome proliferator-activated receptor gamma, coactivator 1 alpha		multiple interactions	ISO	14	64,278,115	64,370,912	RGD:6480464	CTD
G	Ppargc1a	peroxisome proliferator-activated receptor gamma, coactivator 1 alpha		increases expression	EXP	14	64,278,115	64,370,912	RGD:6480464	CTD
G	Prkaca	protein kinase, cAMP-dependent, catalytic, alpha		multiple interactions	EXP	19	25,840,795	25,864,786	RGD:6480464	CTD
G	Rela	v-rel reticuloendotheliosis viral oncogene homolog A (avian)		multiple interactions	EXP	1	208,262,669	208,273,148	RGD:6480464	CTD
G	Tfam	transcription factor A, mitochondrial		increases expression	ISO	20	18,100,629	18,112,682	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Ucp1	uncoupling protein 1 (mitochondrial, proton carrier)		increases expression	ISO	19	26,527,548	26,535,621	RGD:6480464	CTD
diclofenac
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Abcb1b	ATP-binding cassette, subfamily B (MDR/TAP), member 1B		increases expression	ISO	4	21,829,489	21,912,239	RGD:6480464	CTD
G	Abcb1b	ATP-binding cassette, subfamily B (MDR/TAP), member 1B		decreases expression	EXP	4	21,829,489	21,912,239	RGD:6480464	CTD
G	Abcb4	ATP-binding cassette, subfamily B (MDR/TAP), member 4		decreases expression	ISO	4	21,946,274	22,004,328	RGD:6480464	CTD
G	Abcc2	ATP-binding cassette, subfamily C (CFTR/MRP), member 2		decreases activity	ISO				RGD:6480464	CTD
G	Acox1	acyl-CoA oxidase 1, palmitoyl		increases expression	EXP	10	106,281,977	106,319,382	RGD:6480464	CTD
G	Actn1	actinin, alpha 1		affects expression	EXP	6	103,188,593	103,282,873	RGD:6480464	CTD
G	Adk	adenosine kinase		increases expression	ISO	15	3,071,412	3,458,891	RGD:6480464	CTD
G	Adk	adenosine kinase		decreases expression	EXP	15	3,071,412	3,458,891	RGD:6480464	CTD
G	Alb	albumin		affects binding	ISO	14	19,126,935	19,142,214	RGD:6480464	CTD
G	Alb	albumin		increases expression	ISO	14	19,126,935	19,142,214	RGD:6480464	CTD
G	Alb	albumin		increases expression	EXP	14	19,126,935	19,142,214	RGD:6480464	CTD
G	Aqp2	aquaporin 2 (collecting duct)		decreases expression	EXP	7	138,325,855	138,330,891	RGD:6480464	CTD
G	Asic1	acid-sensing (proton-gated) ion channel 1		decreases expression	EXP	7	138,414,656	138,443,272	RGD:6480464	CTD
G	Asic2	acid-sensing (proton-gated) ion channel 2		decreases expression	EXP	10	69,103,244	70,190,305	RGD:6480464	CTD
G	Asic3	acid-sensing (proton-gated) ion channel 3		decreases expression	EXP	4	6,125,614	6,129,660	RGD:6480464	CTD
G	Asic3	acid-sensing (proton-gated) ion channel 3		decreases activity	EXP	4	6,125,614	6,129,660	RGD:6480464	CTD
G	Bak1	BCL2-antagonist/killer 1		increases activity	ISO	20	5,255,954	5,264,593	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		increases activity	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		affects localization	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bcl2l1	Bcl2-like 1		increases expression	ISO	3	143,129,087	143,180,199	RGD:6480464	CTD
G	Bid	BH3 interacting domain death agonist		multiple interactions	ISO	4	157,296,383	157,318,481	RGD:6480464	CTD
G	Bid	BH3 interacting domain death agonist		increases activity	ISO	4	157,296,383	157,318,481	RGD:6480464	CTD
G	Calca	calcitonin-related polypeptide alpha		decreases expression	EXP	1	172,686,168	172,691,061	RGD:6480464	CTD
G	Calr	calreticulin		affects expression	EXP	19	24,964,775	24,969,670	RGD:6480464	CTD
G	Calr	calreticulin		decreases expression	EXP	19	24,964,775	24,969,670	RGD:6480464	CTD
G	Casp2	caspase 2		multiple interactions	ISO	4	70,029,728	70,047,164	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		increases activity	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	EXP	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		increases activity	EXP	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		increases activity	EXP	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp8	caspase 8		increases activity	EXP	9	57,389,353	57,437,803	RGD:6480464	CTD
G	Casp8	caspase 8		multiple interactions	ISO	9	57,389,353	57,437,803	RGD:6480464	CTD
G	Casp9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	ISO	5	160,704,234	160,721,796	RGD:6480464	CTD
G	Casp9	caspase 9, apoptosis-related cysteine peptidase		increases activity	EXP	5	160,704,234	160,721,796	RGD:6480464	CTD
G	Cat	catalase		increases activity	EXP	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Ccl2	chemokine (C-C motif) ligand 2		increases expression	ISO	10	70,256,263	70,258,061	RGD:6480464	CTD
G	Ccnd1	cyclin D1		multiple interactions	ISO	1	205,357,235	205,366,757	RGD:6480464	CTD
G	Ccnd1	cyclin D1		decreases expression	ISO	1	205,357,235	205,366,757	RGD:6480464	CTD
G	Ccnd1	cyclin D1		increases expression	ISO	1	205,357,235	205,366,757	RGD:6480464	CTD
G	Ccnd1	cyclin D1		decreases expression	EXP	1	205,357,235	205,366,757	RGD:6480464	CTD
G	Ccng1	cyclin G1		increases expression	EXP	10	25,776,380	25,782,754	RGD:6480464	CTD
G	Cdh1	cadherin 1		increases expression	ISO	19	36,442,693	36,512,091	RGD:6480464	CTD
G	Cdh1	cadherin 1		decreases expression	EXP	19	36,442,693	36,512,091	RGD:6480464	CTD
G	Cdkn1a	cyclin-dependent kinase inhibitor 1A		increases expression	ISO	20	7,376,325	7,386,778	RGD:6480464	CTD
G	Cdkn1a	cyclin-dependent kinase inhibitor 1A		increases expression	EXP	20	7,376,325	7,386,778	RGD:6480464	CTD
G	Cebpb	CCAAT/enhancer binding protein (C/EBP), beta		increases expression	ISO	3	158,826,021	158,827,848	RGD:6480464	CTD
G	Cebpb	CCAAT/enhancer binding protein (C/EBP), beta		increases expression	EXP	3	158,826,021	158,827,848	RGD:6480464	CTD
G	Cflar	CASP8 and FADD-like apoptosis regulator		multiple interactions	ISO	9	57,309,836	57,356,635	RGD:6480464	CTD
G	Chuk	conserved helix-loop-helix ubiquitous kinase		multiple interactions	ISO	1	249,122,845	249,158,369	RGD:6480464	CTD
G	Cpt1a	carnitine palmitoyltransferase 1a, liver		increases expression	ISO	1	205,852,800	205,912,972	RGD:6480464	CTD
G	Cpt1a	carnitine palmitoyltransferase 1a, liver		increases expression	EXP	1	205,852,800	205,912,972	RGD:6480464	CTD
G	Cxcl2	chemokine (C-X-C motif) ligand 2		increases expression	ISO	14	18,677,129	18,679,175	RGD:6480464	CTD
G	Cyp1a1	cytochrome P450, family 1, subfamily a, polypeptide 1		increases expression	ISO	8	61,462,207	61,468,237	RGD:6480464	CTD
G	Cyp1a1	cytochrome P450, family 1, subfamily a, polypeptide 1		decreases activity	ISO	8	61,462,207	61,468,237	RGD:6480464	CTD
G	Cyp1a2	cytochrome P450, family 1, subfamily a, polypeptide 2		increases expression	ISO	8	61,439,062	61,447,861	RGD:6480464	CTD
G	Cyp1b1	cytochrome P450, family 1, subfamily b, polypeptide 1		decreases activity	ISO	6	2,548,224	2,553,767	RGD:6480464	CTD
G	Cyp2a3	cytochrome P450, family 2, subfamily a, polypeptide 3		decreases activity	ISO	1	81,944,896	81,953,007	RGD:6480464	CTD
G	Cyp2b1	cytochrome P450, family 2, subfamily b, polypeptide 1		decreases activity	ISO	1	81,266,828	81,290,471	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		increases metabolic processing	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		multiple interactions	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		multiple interactions	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		multiple interactions	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		multiple interactions	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		multiple interactions	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		decreases hydroxylation	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		affects metabolic processing	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		increases hydroxylation	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		affects binding	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		increases oxidation	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		increases metabolic processing	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		decreases activity	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		increases activity	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		multiple interactions	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		multiple interactions	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		multiple interactions	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		affects metabolic processing	EXP	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		increases metabolic processing	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		increases hydroxylation	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		increases metabolic processing	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		increases hydroxylation	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		affects metabolic processing	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		increases hydroxylation	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		increases metabolic processing	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		increases metabolic processing	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		increases hydroxylation	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		affects hydrolysis	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		increases hydrolysis	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		decreases activity	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2c6v1	cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1		increases hydroxylation	EXP	1	243,859,015	243,896,003	RGD:6480464	CTD
G	Cyp2c7	cytochrome P450, family 2, subfamily c, polypeptide 7		decreases activity	ISO				RGD:6480464	CTD
G	Cyp3a2	cytochrome P450, family 3, subfamily a, polypeptide 2		increases expression	ISO	12	9,517,016	9,541,000	RGD:6480464	CTD
G	Cyp3a2	cytochrome P450, family 3, subfamily a, polypeptide 2		decreases activity	ISO	12	9,517,016	9,541,000	RGD:6480464	CTD
G	Cyp3a2	cytochrome P450, family 3, subfamily a, polypeptide 2		decreases activity	ISO	12	9,517,016	9,541,000	RGD:6480464	CTD
G	Cyp3a23/3a1	cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1		increases expression	EXP	12	9,567,120	9,595,974	RGD:6480464	CTD
G	Cyp46a1	cytochrome P450, family 46, subfamily a, polypeptide 1		increases hydroxylation	ISO	6	132,700,554	132,731,982	RGD:6480464	CTD
G	Ddit3	DNA-damage inducible transcript 3		increases response to substance	ISO	7	67,247,749	67,252,571	RGD:6480464	CTD
G	Ddit3	DNA-damage inducible transcript 3		increases expression	ISO	7	67,247,749	67,252,571	RGD:6480464	CTD
G	Ddit3	DNA-damage inducible transcript 3		increases expression	EXP	7	67,247,749	67,252,571	RGD:6480464	CTD
G	Edn1	endothelin 1		multiple interactions	ISO	17	28,303,886	28,309,775	RGD:6480464	CTD
G	Egr1	early growth response 1		increases expression	ISO	18	27,343,919	27,346,117	RGD:6480464	CTD
G	Eif4ebp1	eukaryotic translation initiation factor 4E binding protein 1		increases expression	EXP	16	69,110,522	69,123,895	RGD:6480464	CTD
G	Epas1	endothelial PAS domain protein 1		decreases expression	ISO	6	10,203,108	10,297,215	RGD:6480464	CTD
G	Ephx1	epoxide hydrolase 1, microsomal (xenobiotic)		decreases expression	EXP	13	96,722,973	96,752,940	RGD:6480464	CTD
G	Fabp1	fatty acid binding protein 1, liver		decreases expression	ISO	4	104,412,200	104,415,981	RGD:6480464	CTD
G	Fabp2	fatty acid binding protein 2, intestinal		decreases expression	EXP	2	219,591,502	219,605,097	RGD:6480464	CTD
G	Faslg	Fas ligand (TNF superfamily, member 6)		increases expression	ISO	13	77,472,950	77,480,210	RGD:6480464	CTD
G	Fasn	fatty acid synthase		decreases expression	EXP				RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		increases expression	ISO	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Gadd45a	growth arrest and DNA-damage-inducible, alpha		increases expression	ISO	4	96,649,941	96,652,243	RGD:6480464	CTD
G	Gadd45a	growth arrest and DNA-damage-inducible, alpha		increases expression	EXP	4	96,649,941	96,652,243	RGD:6480464	CTD
G	Gadd45a	growth arrest and DNA-damage-inducible, alpha		increases expression	EXP	4	96,649,941	96,652,243	RGD:6480464	CTD
G	Gclc	glutamate-cysteine ligase, catalytic subunit		decreases expression	EXP	8	82,724,429	82,762,848	RGD:6480464	CTD
G	Gclc	glutamate-cysteine ligase, catalytic subunit		affects response to substance	EXP	8	82,724,429	82,762,848	RGD:6480464	CTD
G	Gdf15	growth differentiation factor 15		increases expression	ISO	16	19,310,882	19,313,465	RGD:6480464	CTD
G	Gdf15	growth differentiation factor 15		increases expression	ISO	16	19,310,882	19,313,465	RGD:6480464	CTD
G	Hba1	hemoglobin, alpha 1		increases expression	EXP	10	15,584,360	15,585,215	RGD:6480464	CTD
G	Hbb	hemoglobin, beta		increases expression	EXP	1	161,618,782	161,620,193	RGD:6480464	CTD
G	Hif1a	hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)		decreases expression	ISO	6	96,419,024	96,463,891	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		multiple interactions	ISO	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		increases expression	ISO	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		increases expression	EXP	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		increases expression	EXP	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		increases expression	ISO	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		affects expression	ISO	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hnf4a	hepatocyte nuclear factor 4, alpha		decreases expression	EXP	3	154,459,863	154,482,825	RGD:6480464	CTD
G	Hpgd	hydroxyprostaglandin dehydrogenase 15 (NAD)		increases expression	ISO	16	37,419,901	37,457,896	RGD:6480464	CTD
G	Hpgd	hydroxyprostaglandin dehydrogenase 15 (NAD)		increases activity	ISO	16	37,419,901	37,457,896	RGD:6480464	CTD
G	Hspa1a	heat shock protein 1A		increases expression	EXP	20	3,945,716	3,959,552	RGD:6480464	CTD
G	Icam1	intercellular adhesion molecule 1		multiple interactions	EXP	8	20,040,177	20,051,939	RGD:6480464	CTD
G	Icam1	intercellular adhesion molecule 1		decreases expression	EXP	8	20,040,177	20,051,939	RGD:6480464	CTD
G	Icam1	intercellular adhesion molecule 1		decreases expression	EXP	8	20,040,177	20,051,939	RGD:6480464	CTD
G	Ifng	interferon gamma		multiple interactions	EXP	7	57,621,756	57,625,792	RGD:6480464	CTD
G	Ifng	interferon gamma		decreases expression	ISO	7	57,621,756	57,625,792	RGD:6480464	CTD
G	Il10	interleukin 10		increases response to substance	ISO	13	43,953,900	43,957,766	RGD:6480464	CTD
G	Il17a	interleukin 17A		increases expression	ISO	9	19,454,979	19,458,467	RGD:6480464	CTD
G	Il17a	interleukin 17A		increases expression	ISO	9	19,454,979	19,458,467	RGD:6480464	CTD
G	Il1a	interleukin 1 alpha		multiple interactions	ISO	3	116,913,612	116,924,114	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		increases expression	EXP	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		multiple interactions	ISO	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		multiple interactions	EXP	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		increases expression	ISO	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il4	interleukin 4		increases response to substance	ISO	10	39,074,582	39,080,134	RGD:6480464	CTD
G	Il5	interleukin 5		multiple interactions	ISO	10	39,177,786	39,180,657	RGD:6480464	CTD
G	Il6	interleukin 6		multiple interactions	ISO	4	456,799	461,376	RGD:6480464	CTD
G	Itgb3	integrin, beta 3		multiple interactions	ISO				RGD:6480464	CTD
G	Jund	jun D proto-oncogene		increases expression	ISO	16	19,239,694	19,241,529	RGD:6480464	CTD
G	Jund	jun D proto-oncogene		increases expression	EXP	16	19,239,694	19,241,529	RGD:6480464	CTD
G	Map3k12	mitogen activated protein kinase kinase kinase 12		decreases expression	EXP	7	141,254,451	141,264,979	RGD:6480464	CTD
G	Mdm2	p53 E3 ubiquitin protein ligase		decreases expression	EXP	7	56,996,694	57,020,926	RGD:6480464	CTD
G	Mt-co2	mitochondrially encoded cytochrome c oxidase II		increases expression	ISO	MT	7,006	7,689	RGD:6480464	CTD
G	Mup1	major urinary protein 1		increases expression	EXP				RGD:6480464	CTD
G	Myc	myelocytomatosis oncogene		increases expression	EXP	7	98,953,142	98,958,060	RGD:6480464	CTD
G	Myc	myelocytomatosis oncogene		increases expression	ISO	7	98,953,142	98,958,060	RGD:6480464	CTD
G	Nfkb1	nuclear factor of kappa light polypeptide gene enhancer in B-cells 1		multiple interactions	ISO	2	233,091,013	233,187,501	RGD:6480464	CTD
G	Nfkbia	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha		multiple interactions	ISO	6	75,729,302	75,732,475	RGD:6480464	CTD
G	Nfkbia	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha		decreases expression	EXP	6	75,729,302	75,732,475	RGD:6480464	CTD
G	Nfkbia	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha		multiple interactions	EXP	6	75,729,302	75,732,475	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		increases expression	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		multiple interactions	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		increases expression	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nqo1	NAD(P)H dehydrogenase, quinone 1		increases activity	ISO	19	37,251,147	37,266,040	RGD:6480464	CTD
G	Nqo1	NAD(P)H dehydrogenase, quinone 1		increases expression	EXP	19	37,251,147	37,266,040	RGD:6480464	CTD
G	Nr1i2	nuclear receptor subfamily 1, group I, member 2		increases expression	ISO	11	64,239,918	64,276,702	RGD:6480464	CTD
G	Pdcd4	programmed cell death 4		decreases expression	ISO	1	260,183,648	260,202,032	RGD:6480464	CTD
G	Pdcd4	programmed cell death 4		increases expression	ISO	1	260,183,648	260,202,032	RGD:6480464	CTD
G	Pparg	peroxisome proliferator-activated receptor gamma		increases activity	ISO	4	151,492,220	151,617,331	RGD:6480464	CTD
G	Ppif	peptidylprolyl isomerase F		increases response to substance	ISO	16	1,292,835	1,299,556	RGD:6480464	CTD
G	Psmb4	proteasome (prosome, macropain) subunit, beta type 4		decreases expression	EXP	2	189,778,476	189,781,169	RGD:6480464	CTD
G	Ptges	prostaglandin E synthase		decreases expression	EXP	3	9,946,194	9,957,538	RGD:6480464	CTD
G	Ptges	prostaglandin E synthase		multiple interactions	EXP	3	9,946,194	9,957,538	RGD:6480464	CTD
G	Ptgs1	prostaglandin-endoperoxide synthase 1		decreases activity	ISO	3	15,343,832	15,365,412	RGD:6480464	CTD
G	Ptgs1	prostaglandin-endoperoxide synthase 1		decreases activity	ISO	3	15,343,832	15,365,412	RGD:6480464	CTD
G	Ptgs1	prostaglandin-endoperoxide synthase 1		decreases expression	EXP	3	15,343,832	15,365,412	RGD:6480464	CTD
G	Ptgs1	prostaglandin-endoperoxide synthase 1		decreases activity	EXP	3	15,343,832	15,365,412	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		multiple interactions	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		decreases activity	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		multiple interactions	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		multiple interactions	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		multiple interactions	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		decreases activity	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		increases expression	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		increases expression	EXP	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		increases expression	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		decreases activity	EXP	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Rela	v-rel reticuloendotheliosis viral oncogene homolog A (avian)		multiple interactions	ISO	1	208,262,669	208,273,148	RGD:6480464	CTD
G	Rela	v-rel reticuloendotheliosis viral oncogene homolog A (avian)		multiple interactions	EXP	1	208,262,669	208,273,148	RGD:6480464	CTD
G	Rgn	regucalcin (senescence marker protein-30)		increases expression	EXP	X	13,037,171	13,052,846	RGD:6480464	CTD
G	RT1-Bb	RT1 class II, locus Bb		decreases expression	EXP	20	4,730,559	4,736,201	RGD:6480464	CTD
G	Sell	selectin L		decreases expression	ISO	13	79,827,342	79,845,296	RGD:6480464	CTD
G	Selp	selectin P		decreases expression	EXP	13	79,886,614	79,922,180	RGD:6480464	CTD
G	Selp	selectin P		multiple interactions	EXP	13	79,886,614	79,922,180	RGD:6480464	CTD
G	Slc22a1	solute carrier family 22 (organic cation transporter), member 1		decreases activity	ISO	1	42,351,239	42,378,295	RGD:6480464	CTD
G	Slc22a24	solute carrier family 22, member 24		multiple interactions	EXP	1	210,409,224	210,465,549	RGD:6480464	CTD
G	Slc22a6	solute carrier family 22 (organic anion transporter), member 6		decreases activity	ISO	1	211,294,178	211,302,398	RGD:6480464	CTD
G	Slc22a7	solute carrier family 22 (organic anion transporter), member 7		decreases activity	ISO	9	9,934,309	9,940,107	RGD:6480464	CTD
G	Slc22a7	solute carrier family 22 (organic anion transporter), member 7		multiple interactions	ISO	9	9,934,309	9,940,107	RGD:6480464	CTD
G	Slc22a8	solute carrier family 22 (organic anion transporter), member 8		multiple interactions	ISO	1	211,269,366	211,287,596	RGD:6480464	CTD
G	Slc23a2	solute carrier family 23 (nucleobase transporters), member 2		multiple interactions	ISO	3	119,796,376	119,886,011	RGD:6480464	CTD
G	Slco2a1	solute carrier organic anion transporter family, member 2a1		multiple interactions	ISO	8	108,012,829	108,098,561	RGD:6480464	CTD
G	Sod2	superoxide dismutase 2, mitochondrial		increases expression	ISO	1	41,862,997	41,870,327	RGD:6480464	CTD
G	Sod2	superoxide dismutase 2, mitochondrial		increases expression	EXP	1	41,862,997	41,870,327	RGD:6480464	CTD
G	Stat1	signal transducer and activator of transcription 1		decreases expression	ISO	9	46,455,635	46,497,560	RGD:6480464	CTD
G	Stat3	signal transducer and activator of transcription 3 (acute-phase response factor)		increases expression	ISO	10	89,821,078	89,872,970	RGD:6480464	CTD
G	Tbx21	T-box 21		decreases expression	ISO	10	85,817,743	85,834,178	RGD:6480464	CTD
G	Tgfa	transforming growth factor alpha		increases expression	ISO	4	120,355,649	120,437,772	RGD:6480464	CTD
G	Timp1	TIMP metallopeptidase inhibitor 1		decreases expression	EXP	X	12,542,496	12,547,094	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		increases expression	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		increases expression	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		increases expression	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tp53	tumor protein p53		multiple interactions	ISO	10	56,399,721	56,411,150	RGD:6480464	CTD
G	Tpd52	tumor protein D52		increases expression	ISO	2	94,850,203	94,880,802	RGD:6480464	CTD
G	Txn1	thioredoxin 1		increases expression	ISO	5	75,921,365	75,933,595	RGD:6480464	CTD
G	Txn2	thioredoxin 2		increases expression	EXP	7	115,833,695	115,847,690	RGD:6480464	CTD
G	Tyr	tyrosinase		decreases expression	ISO	1	143,641,257	143,746,315	RGD:6480464	CTD
G	Ugt1a1	UDP glucuronosyltransferase 1 family, polypeptide A1		increases expression	ISO	9	87,091,241	87,098,362	RGD:6480464	CTD
G	Ugt1a1	UDP glucuronosyltransferase 1 family, polypeptide A1		decreases activity	ISO	9	87,091,241	87,098,362	RGD:6480464	CTD
G	Ugt1a1	UDP glucuronosyltransferase 1 family, polypeptide A1		decreases expression	EXP	9	87,091,241	87,098,362	RGD:6480464	CTD
G	Ugt1a1	UDP glucuronosyltransferase 1 family, polypeptide A1		decreases activity	ISO	9	87,091,241	87,098,362	RGD:6480464	CTD
G	Ugt1a2	UDP glucuronosyltransferase 1 family, polypeptide A2		decreases activity	ISO	9	87,081,132	87,098,362	RGD:6480464	CTD
G	Ugt1a2	UDP glucuronosyltransferase 1 family, polypeptide A2		increases glucuronidation	ISO	9	87,081,132	87,098,362	RGD:6480464	CTD
G	Ugt1a2	UDP glucuronosyltransferase 1 family, polypeptide A2		increases glucuronidation	ISO	9	87,081,132	87,098,362	RGD:6480464	CTD
G	Ugt1a6	UDP glucuronosyltransferase 1 family, polypeptide A6		multiple interactions	ISO	9	87,037,154	87,098,362	RGD:6480464	CTD
G	Ugt1a8	UDP glycosyltransferase 1 family, polypeptide A8		increases glucuronidation	ISO	9	87,017,029	87,098,362	RGD:6480464	CTD
G	Ugt1a9	UDP glucuronosyltransferase 1 family, polypeptide A9		increases glucuronidation	ISO	9	86,986,915	87,098,362	RGD:6480464	CTD
G	Ugt2b15	UDP glucuronosyltransferase 2 family, polypeptide B15		increases glucuronidation	ISO	14	22,346,334	22,366,860	RGD:6480464	CTD
G	Ugt2b15	UDP glucuronosyltransferase 2 family, polypeptide B15		increases glucuronidation	ISO	14	22,346,334	22,366,860	RGD:6480464	CTD
G	Ugt2b15	UDP glucuronosyltransferase 2 family, polypeptide B15		decreases activity	ISO	14	22,346,334	22,366,860	RGD:6480464	CTD
G	Ugt2b17	UDP glucuronosyltransferase 2 family, polypeptide B17		increases glucuronidation	ISO	14	22,639,182	22,650,931	RGD:6480464	CTD
G	Ugt2b17	UDP glucuronosyltransferase 2 family, polypeptide B17		increases glucuronidation	ISO	14	22,639,182	22,650,931	RGD:6480464	CTD
G	Ugt2b35	UDP glucuronosyltransferase 2 family, polypeptide B35		decreases activity	ISO	14	22,454,256	22,493,510	RGD:6480464	CTD
G	Ugt2b35	UDP glucuronosyltransferase 2 family, polypeptide B35		increases glucuronidation	ISO	14	22,454,256	22,493,510	RGD:6480464	CTD
G	Ugt2b7	UDP glucuronosyltransferase 2 family, polypeptide B7		multiple interactions	ISO	14	22,499,152	22,522,842	RGD:6480464	CTD
G	Ugt2b7	UDP glucuronosyltransferase 2 family, polypeptide B7		increases glucuronidation	ISO	14	22,499,152	22,522,842	RGD:6480464	CTD
G	Ugt2b7	UDP glucuronosyltransferase 2 family, polypeptide B7		multiple interactions	ISO	14	22,499,152	22,522,842	RGD:6480464	CTD
G	Ugt2b7	UDP glucuronosyltransferase 2 family, polypeptide B7		increases glucuronidation	ISO	14	22,499,152	22,522,842	RGD:6480464	CTD
G	Ugt2b7	UDP glucuronosyltransferase 2 family, polypeptide B7		increases glucuronidation	ISO	14	22,499,152	22,522,842	RGD:6480464	CTD
G	Ugt2b7	UDP glucuronosyltransferase 2 family, polypeptide B7		increases glucuronidation	ISO	14	22,499,152	22,522,842	RGD:6480464	CTD
G	Ugt2b7	UDP glucuronosyltransferase 2 family, polypeptide B7		increases glucuronidation	ISO	14	22,499,152	22,522,842	RGD:6480464	CTD
G	Ugt2b7	UDP glucuronosyltransferase 2 family, polypeptide B7		increases glucuronidation	ISO	14	22,499,152	22,522,842	RGD:6480464	CTD
G	UST4r	integral membrane transport protein UST4r		decreases activity	ISO	1	210,618,706	210,688,125	RGD:6480464	CTD
G	Vim	vimentin		decreases expression	ISO	17	87,847,280	87,855,763	RGD:6480464	CTD
G	Zeb1	zinc finger E-box binding homeobox 1		decreases expression	ISO	17	60,177,150	60,198,584	RGD:6480464	CTD
dimethylamine
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Hrh3	histamine receptor H3		multiple interactions	ISO	3	169,154,980	169,160,064	RGD:6480464	CTD
G	Hrh3	histamine receptor H3		multiple interactions	EXP	3	169,154,980	169,160,064	RGD:6480464	CTD
dobutamine
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Adcy6	adenylate cyclase 6		affects response to substance	ISO	7	137,339,933	137,360,020	RGD:6480464	CTD
G	Adra2a	adrenoceptor alpha 2A		multiple interactions	ISO				RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		affects response to substance	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		affects response to substance	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	EXP	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	EXP	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	EXP	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		affects response to substance	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		affects response to substance	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb3	adrenoceptor beta 3		multiple interactions	EXP	16	69,163,620	69,166,384	RGD:6480464	CTD
G	Ahsg	alpha-2-HS-glycoprotein		affects response to substance	ISO	11	80,330,615	80,336,658	RGD:6480464	CTD
G	Akt1	v-akt murine thymoma viral oncogene homolog 1		affects response to substance	ISO	6	137,640,482	137,657,552	RGD:6480464	CTD
G	Akt1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	EXP	6	137,640,482	137,657,552	RGD:6480464	CTD
G	Akt2	v-akt murine thymoma viral oncogene homolog 2		multiple interactions	EXP	1	82,686,233	82,726,544	RGD:6480464	CTD
G	Akt3	v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma)		multiple interactions	EXP	13	92,802,390	93,110,704	RGD:6480464	CTD
G	Arrb1	arrestin, beta 1		multiple interactions	ISO	1	156,871,564	156,937,540	RGD:6480464	CTD
G	Arrb2	arrestin, beta 2		multiple interactions	ISO	10	57,244,071	57,284,166	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		increases expression	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		decreases expression	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bnip1	BCL2/adenovirus E1B interacting protein 1		increases expression	ISO	10	16,648,619	16,660,896	RGD:6480464	CTD
G	Ccl2	chemokine (C-C motif) ligand 2		multiple interactions	ISO	10	70,256,263	70,258,061	RGD:6480464	CTD
G	Ccl3	chemokine (C-C motif) ligand 3		multiple interactions	ISO	10	71,744,559	71,746,109	RGD:6480464	CTD
G	Clu	clusterin		increases expression	ISO	15	45,365,779	45,405,314	RGD:6480464	CTD
G	Comt	catechol-O-methyltransferase		increases methylation	ISO	11	84,561,591	84,581,713	RGD:6480464	CTD
G	Comt	catechol-O-methyltransferase		increases expression	EXP	11	84,561,591	84,581,713	RGD:6480464	CTD
G	Cpt1a	carnitine palmitoyltransferase 1a, liver		increases expression	EXP	1	205,852,800	205,912,972	RGD:6480464	CTD
G	Crem	cAMP responsive element modulator		affects response to substance	ISO	17	62,770,633	62,837,670	RGD:6480464	CTD
G	Ctf1	cardiotrophin 1		affects response to substance	ISO	1	187,001,445	187,006,655	RGD:6480464	CTD
G	Cxcl2	chemokine (C-X-C motif) ligand 2		multiple interactions	ISO	14	18,677,129	18,679,175	RGD:6480464	CTD
G	Dbh	dopamine beta-hydroxylase (dopamine beta-monooxygenase)		affects response to substance	ISO	3	6,052,706	6,069,826	RGD:6480464	CTD
G	Dmd	dystrophin		increases response to substance	ISO	X	71,501,362	71,671,414	RGD:6480464	CTD
G	Egfr	epidermal growth factor receptor		decreases response to substance	ISO	14	97,617,358	97,788,211	RGD:6480464	CTD
G	Egfr	epidermal growth factor receptor		multiple interactions	ISO	14	97,617,358	97,788,211	RGD:6480464	CTD
G	F3	coagulation factor III (thromboplastin, tissue factor)		increases expression	ISO	2	218,371,050	218,382,645	RGD:6480464	CTD
G	Fgf2	fibroblast growth factor 2		affects response to substance	ISO	2	123,893,314	123,947,136	RGD:6480464	CTD
G	Fgf2	fibroblast growth factor 2		affects response to substance	ISO	2	123,893,314	123,947,136	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		multiple interactions	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	G6pd	glucose-6-phosphate dehydrogenase		increases activity	EXP	X	160,186,450	160,192,316	RGD:6480464	CTD
G	Gh1	growth hormone 1		multiple interactions	EXP	10	95,692,240	95,694,117	RGD:6480464	CTD
G	Gk	glycerol kinase		increases activity	EXP	X	72,416,872	72,493,296	RGD:6480464	CTD
G	Gnas	GNAS complex locus		increases response to substance	ISO	3	165,213,399	165,214,551	RGD:6480464	CTD
G	Gsk3b	glycogen synthase kinase 3 beta		affects response to substance	ISO	11	64,284,731	64,428,698	RGD:6480464	CTD
G	Hbegf	heparin-binding EGF-like growth factor		multiple interactions	ISO	18	29,143,567	29,153,944	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		increases expression	EXP	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		increases expression	EXP	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		multiple interactions	EXP	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		multiple interactions	EXP	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		increases expression	EXP	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Igf1	insulin-like growth factor 1		increases response to substance	EXP	7	24,531,669	24,605,742	RGD:6480464	CTD
G	Il10	interleukin 10		multiple interactions	ISO	13	43,953,900	43,957,766	RGD:6480464	CTD
G	Il10	interleukin 10		multiple interactions	ISO	13	43,953,900	43,957,766	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		increases expression	EXP	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il6	interleukin 6		increases expression	ISO	4	456,799	461,376	RGD:6480464	CTD
G	Il6	interleukin 6		multiple interactions	ISO	4	456,799	461,376	RGD:6480464	CTD
G	Il6	interleukin 6		decreases expression	EXP	4	456,799	461,376	RGD:6480464	CTD
G	Itgb1	integrin, beta 1		affects response to substance	ISO	19	58,600,095	58,647,531	RGD:6480464	CTD
G	Jun	jun proto-oncogene		multiple interactions	EXP	5	115,358,166	115,361,259	RGD:6480464	CTD
G	Jund	jun D proto-oncogene		multiple interactions	EXP	16	19,239,694	19,241,529	RGD:6480464	CTD
G	Kcnj11	potassium inwardly rectifying channel, subfamily J, member 11		multiple interactions	ISO	1	96,614,960	96,617,993	RGD:6480464	CTD
G	Kcnj11	potassium inwardly rectifying channel, subfamily J, member 11		affects response to substance	ISO	1	96,614,960	96,617,993	RGD:6480464	CTD
G	Klk1	kallikrein 1		affects response to substance	ISO	1	94,624,828	94,628,822	RGD:6480464	CTD
G	Lep	leptin		decreases secretion	ISO	4	55,943,837	55,945,938	RGD:6480464	CTD
G	Lep	leptin		decreases expression	ISO	4	55,943,837	55,945,938	RGD:6480464	CTD
G	Lepr	leptin receptor		affects response to substance	ISO	5	122,320,075	122,503,449	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	EXP	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		increases phosphorylation	EXP	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	ISO	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	EXP	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		increases phosphorylation	EXP	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	ISO	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mapk9	mitogen-activated protein kinase 9		multiple interactions	EXP	10	35,353,486	35,384,319	RGD:6480464	CTD
G	Mb	myoglobin		affects response to substance	ISO	7	115,087,558	115,094,789	RGD:6480464	CTD
G	Nfkbia	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha		multiple interactions	ISO	6	75,729,302	75,732,475	RGD:6480464	CTD
G	Nos1	nitric oxide synthase 1, neuronal		affects response to substance	ISO	12	39,812,500	39,869,484	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		affects response to substance	ISO	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		affects response to substance	ISO	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Phgdh	phosphoglycerate dehydrogenase		increases expression	EXP	2	193,147,943	193,177,137	RGD:6480464	CTD
G	Pln	phospholamban		affects response to substance	ISO	20	32,000,371	32,008,559	RGD:6480464	CTD
G	Ppp2ca	protein phosphatase 2, catalytic subunit, alpha isozyme		affects response to substance	ISO	10	37,621,256	37,641,008	RGD:6480464	CTD
G	Prkaca	protein kinase, cAMP-dependent, catalytic, alpha		multiple interactions	EXP	19	25,840,795	25,864,786	RGD:6480464	CTD
G	Prkce	protein kinase C, epsilon		affects response to substance	ISO	6	9,631,234	10,097,311	RGD:6480464	CTD
G	Prop1	PROP paired-like homeobox 1		decreases response to substance	ISO	10	36,527,112	36,529,573	RGD:6480464	CTD
G	Ren	renin		multiple interactions	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		increases activity	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		increases secretion	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		increases expression	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	S100a1	S100 calcium binding protein A1		increases response to substance	ISO	2	182,784,818	182,787,370	RGD:6480464	CTD
G	Scnn1g	sodium channel, nonvoltage-gated 1, gamma		increases expression	EXP	1	180,555,660	180,589,534	RGD:6480464	CTD
G	Sgcd	sarcoglycan, delta (dystrophin-associated glycoprotein)		affects response to substance	ISO	10	32,084,678	32,489,330	RGD:6480464	CTD
G	Sptan1	spectrin, alpha, non-erythrocytic 1		increases degradation	EXP	3	8,956,380	9,021,831	RGD:6480464	CTD
G	Tac1	tachykinin, precursor 1		multiple interactions	ISO	4	32,649,666	32,657,632	RGD:6480464	CTD
G	Tacr1	tachykinin receptor 1		multiple interactions	ISO	4	116,610,595	116,780,394	RGD:6480464	CTD
G	Tgfb1	transforming growth factor, beta 1		increases expression	EXP	1	80,894,705	80,911,020	RGD:6480464	CTD
G	Tgfb2	transforming growth factor, beta 2		increases expression	EXP	13	102,718,703	102,818,768	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		decreases expression	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		decreases secretion	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Usf1	upstream transcription factor 1		multiple interactions	ISO	13	87,336,705	87,344,466	RGD:6480464	CTD
G	Vegfa	vascular endothelial growth factor A		affects response to substance	ISO	9	10,520,730	10,536,071	RGD:6480464	CTD
G	Vegfa	vascular endothelial growth factor A		affects response to substance	ISO	9	10,520,730	10,536,071	RGD:6480464	CTD
G	Vegfa	vascular endothelial growth factor A		affects response to substance	ISO	9	10,520,730	10,536,071	RGD:6480464	CTD
fenoterol
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	EXP	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		increases phosphorylation	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	EXP	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb3	adrenoceptor beta 3		multiple interactions	ISO	16	69,163,620	69,166,384	RGD:6480464	CTD
G	Cat	catalase		multiple interactions	ISO	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Ednrb	endothelin receptor type B		increases expression	ISO	15	87,893,141	87,898,700	RGD:6480464	CTD
G	Epo	erythropoietin		increases expression	ISO	12	19,551,768	19,555,208	RGD:6480464	CTD
G	G6pd	glucose-6-phosphate dehydrogenase		increases activity	EXP	X	160,186,450	160,192,316	RGD:6480464	CTD
G	Lep	leptin		decreases secretion	ISO	4	55,943,837	55,945,938	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	ISO	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	ISO	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mpo	myeloperoxidase		multiple interactions	ISO	10	76,085,872	76,097,012	RGD:6480464	CTD
G	Ren	renin		increases activity	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		increases expression	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
flufenamic acid
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Adam17	ADAM metallopeptidase domain 17		increases response to substance	ISO	6	41,882,432	41,930,755	RGD:6480464	CTD
G	Akr1c1	aldo-keto reductase family 1, member C1		decreases activity	ISO	17	77,084,306	77,112,994	RGD:6480464	CTD
G	Akr1c1	aldo-keto reductase family 1, member C1		multiple interactions	ISO	17	77,084,306	77,112,994	RGD:6480464	CTD
G	Akr1c2	aldo-keto reductase family 1, member C2		decreases activity	ISO	17	77,034,737	77,081,406	RGD:6480464	CTD
G	Akr1c2	aldo-keto reductase family 1, member C2		multiple interactions	ISO	17	77,034,737	77,081,406	RGD:6480464	CTD
G	Akr1c3	aldo-keto reductase family 1, member C3		affects binding	ISO	17	77,269,626	77,286,521	RGD:6480464	CTD
G	Akr1c3	aldo-keto reductase family 1, member C3		decreases activity	ISO	17	77,269,626	77,286,521	RGD:6480464	CTD
G	Akr1c3	aldo-keto reductase family 1, member C3		multiple interactions	ISO	17	77,269,626	77,286,521	RGD:6480464	CTD
G	Ar	androgen receptor		multiple interactions	ISO	X	85,949,507	86,119,199	RGD:6480464	CTD
G	Ar	androgen receptor		decreases expression	ISO	X	85,949,507	86,119,199	RGD:6480464	CTD
G	Asic5	acid-sensing (proton-gated) ion channel family member 5		multiple interactions	ISO	2	173,632,309	173,662,245	RGD:6480464	CTD
G	Best1	bestrophin 1		decreases activity	ISO	1	212,432,811	212,449,374	RGD:6480464	CTD
G	Casr	calcium-sensing receptor		multiple interactions	ISO	11	66,084,169	66,153,292	RGD:6480464	CTD
G	Cftr	cystic fibrosis transmembrane conductance regulator		decreases activity	ISO	4	43,874,852	44,041,870	RGD:6480464	CTD
G	Cga	glycoprotein hormones, alpha polypeptide		multiple interactions	EXP	5	51,538,259	51,550,324	RGD:6480464	CTD
G	Chrm1	cholinergic receptor, muscarinic 1		multiple interactions	ISO	1	211,351,738	211,353,120	RGD:6480464	CTD
G	Fshb	follicle stimulating hormone, beta polypeptide		multiple interactions	EXP	3	92,569,344	92,571,254	RGD:6480464	CTD
G	Grm1	glutamate receptor, metabotropic 1		multiple interactions	EXP	1	5,318,617	5,744,593	RGD:6480464	CTD
G	Il1a	interleukin 1 alpha		multiple interactions	ISO	3	116,913,612	116,924,114	RGD:6480464	CTD
G	Il6	interleukin 6		increases expression	EXP	4	456,799	461,376	RGD:6480464	CTD
G	Kcnh2	potassium voltage-gated channel, subfamily H (eag-related), member 2		multiple interactions	ISO	4	6,192,644	6,224,285	RGD:6480464	CTD
G	Kcnk10	potassium channel, subfamily K, member 10		multiple interactions	ISO	6	122,600,156	122,729,583	RGD:6480464	CTD
G	Kcnk2	potassium channel, subfamily K, member 2		multiple interactions	ISO	13	105,376,001	105,574,238	RGD:6480464	CTD
G	Kcnk4	potassium channel, subfamily K, member 4		multiple interactions	ISO	1	209,602,228	209,608,521	RGD:6480464	CTD
G	Kiss1	KiSS-1 metastasis-suppressor		multiple interactions	ISO	13	46,244,786	46,247,288	RGD:6480464	CTD
G	Kiss1r	KISS1 receptor		multiple interactions	ISO	7	11,297,840	11,301,187	RGD:6480464	CTD
G	Ldlr	low density lipoprotein receptor		multiple interactions	ISO	8	20,824,040	20,846,920	RGD:6480464	CTD
G	Ldlr	low density lipoprotein receptor		increases expression	ISO	8	20,824,040	20,846,920	RGD:6480464	CTD
G	Lep	leptin		multiple interactions	ISO	4	55,943,837	55,945,938	RGD:6480464	CTD
G	Lhb	luteinizing hormone beta		multiple interactions	EXP	1	95,892,999	95,893,988	RGD:6480464	CTD
G	Nkx3-1	NK3 homeobox 1		multiple interactions	ISO	15	49,743,313	49,745,905	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		multiple interactions	ISO	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		increases expression	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Panx1	Pannexin 1		decreases activity	ISO	8	11,809,752	11,849,392	RGD:6480464	CTD
G	Ppara	peroxisome proliferator activated receptor alpha		multiple interactions	ISO	7	123,729,774	123,807,090	RGD:6480464	CTD
G	Pparg	peroxisome proliferator-activated receptor gamma		multiple interactions	ISO	4	151,492,220	151,617,331	RGD:6480464	CTD
G	Pparg	peroxisome proliferator-activated receptor gamma		increases activity	ISO	4	151,492,220	151,617,331	RGD:6480464	CTD
G	Pparg	peroxisome proliferator-activated receptor gamma		multiple interactions	ISO	4	151,492,220	151,617,331	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		multiple interactions	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		increases expression	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Sell	selectin L		decreases expression	ISO	13	79,827,342	79,845,296	RGD:6480464	CTD
G	Slc6a11	solute carrier family 6 (neurotransmitter transporter, GABA), member 11		multiple interactions	ISO	4	150,067,441	150,196,237	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		increases expression	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Trpc6	transient receptor potential cation channel, subfamily C, member 6		multiple interactions	ISO	8	5,472,515	5,577,537	RGD:6480464	CTD
G	Trpc6	transient receptor potential cation channel, subfamily C, member 6		increases activity	ISO	8	5,472,515	5,577,537	RGD:6480464	CTD
G	Trpc6	transient receptor potential cation channel, subfamily C, member 6		multiple interactions	EXP	8	5,472,515	5,577,537	RGD:6480464	CTD
G	Trpc6	transient receptor potential cation channel, subfamily C, member 6		increases activity	ISO	8	5,472,515	5,577,537	RGD:6480464	CTD
G	Trpm2	transient receptor potential cation channel, subfamily M, member 2		multiple interactions	EXP	20	11,053,301	11,099,740	RGD:6480464	CTD
G	Trpm4	transient receptor potential cation channel, subfamily M, member 4		decreases activity	ISO	1	95,773,485	95,803,542	RGD:6480464	CTD
G	Trpm4	transient receptor potential cation channel, subfamily M, member 4		decreases activity	EXP	1	95,773,485	95,803,542	RGD:6480464	CTD
p-aminodiphenylamine
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cyp1a1	cytochrome P450, family 1, subfamily a, polypeptide 1		multiple interactions	ISO	8	61,462,207	61,468,237	RGD:6480464	CTD
pindolol
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Adrb1	adrenoceptor beta 1		increases expression	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	EXP	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		increases activity	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		affects binding	EXP	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	EXP	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		decreases expression	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	EXP	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		affects binding	EXP	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb3	adrenoceptor beta 3		multiple interactions	ISO	16	69,163,620	69,166,384	RGD:6480464	CTD
G	Adrb3	adrenoceptor beta 3		multiple interactions	EXP	16	69,163,620	69,166,384	RGD:6480464	CTD
G	Adrb3	adrenoceptor beta 3		multiple interactions	ISO	16	69,163,620	69,166,384	RGD:6480464	CTD
G	Adrb3	adrenoceptor beta 3		multiple interactions	ISO	16	69,163,620	69,166,384	RGD:6480464	CTD
G	Adrb3	adrenoceptor beta 3		multiple interactions	ISO	16	69,163,620	69,166,384	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		multiple interactions	ISO	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Htr1a	5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled		multiple interactions	EXP	2	36,434,518	36,435,786	RGD:6480464	CTD
G	Htr1b	5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled		affects binding	EXP	8	86,700,088	86,701,248	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	ISO	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	ISO	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Prl	prolactin		multiple interactions	ISO	17	44,699,101	44,709,162	RGD:6480464	CTD
G	Prl	prolactin		multiple interactions	EXP	17	44,699,101	44,709,162	RGD:6480464	CTD
G	Ren	renin		multiple interactions	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		decreases activity	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		decreases expression	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
piperidine
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ache	acetylcholinesterase		decreases activity	ISO				RGD:6480464	CTD
G	Ache	acetylcholinesterase		multiple interactions	ISO				RGD:6480464	CTD
G	App	amyloid beta (A4) precursor protein		multiple interactions	ISO	11	24,457,855	24,693,851	RGD:6480464	CTD
G	Bche	butyrylcholinesterase		decreases activity	ISO	2	164,329,613	164,427,994	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		multiple interactions	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Ifng	interferon gamma		multiple interactions	ISO	7	57,621,756	57,625,792	RGD:6480464	CTD
G	Il2	interleukin 2		decreases expression	ISO	2	123,655,005	123,659,709	RGD:6480464	CTD
G	Il2	interleukin 2		multiple interactions	ISO	2	123,655,005	123,659,709	RGD:6480464	CTD
G	Srd5a1	steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)		decreases activity	ISO	17	3,845,190	3,879,165	RGD:6480464	CTD
G	Srd5a1	steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)		decreases activity	EXP	17	3,845,190	3,879,165	RGD:6480464	CTD
G	Srd5a2	steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)		decreases activity	ISO	6	21,453,521	21,489,408	RGD:6480464	CTD
G	Srd5a2	steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)		decreases activity	EXP	6	21,453,521	21,489,408	RGD:6480464	CTD
practolol
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	ISO	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	ISO	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Ren	renin		decreases activity	EXP	13	46,262,936	46,275,213	RGD:6480464	CTD
propranolol
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Abcb1a	ATP-binding cassette, sub-family B (MDR/TAP), member 1A		increases expression	ISO	4	21,709,855	21,796,628	RGD:6480464	CTD
G	Abcb1a	ATP-binding cassette, sub-family B (MDR/TAP), member 1A		multiple interactions	ISO	4	21,709,855	21,796,628	RGD:6480464	CTD
G	Ada	adenosine deaminase		multiple interactions	EXP	3	154,636,530	154,660,637	RGD:6480464	CTD
G	Adm	adrenomedullin		decreases response to substance	EXP	1	168,380,255	168,382,426	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		affects binding	EXP	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	EXP	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		affects binding	EXP	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		affects response to substance	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		affects binding	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		increases activity	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		affects binding	EXP	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	EXP	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		increases expression	EXP	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		affects binding	EXP	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		affects binding	EXP	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		affects binding	EXP	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb1	adrenoceptor beta 1		multiple interactions	ISO	1	263,025,655	263,027,055	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		decreases expression	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		affects binding	EXP	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	EXP	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		affects binding	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		affects binding	EXP	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		affects binding	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		affects binding	EXP	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	EXP	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		increases expression	EXP	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		affects binding	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		affects binding	EXP	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	ISO	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb2	adrenoceptor beta 2, surface		multiple interactions	EXP	18	58,174,958	58,177,000	RGD:6480464	CTD
G	Adrb3	adrenoceptor beta 3		multiple interactions	ISO	16	69,163,620	69,166,384	RGD:6480464	CTD
G	Adrb3	adrenoceptor beta 3		affects response to substance	ISO	16	69,163,620	69,166,384	RGD:6480464	CTD
G	Adrbk1	adrenergic, beta, receptor kinase 1		multiple interactions	ISO	1	206,873,002	206,892,868	RGD:6480464	CTD
G	Adrbk1	adrenergic, beta, receptor kinase 1		decreases expression	ISO	1	206,873,002	206,892,868	RGD:6480464	CTD
G	Adrbk1	adrenergic, beta, receptor kinase 1		increases expression	ISO	1	206,873,002	206,892,868	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		multiple interactions	ISO	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		decreases expression	ISO	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		multiple interactions	ISO	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		multiple interactions	ISO	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		multiple interactions	ISO	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Alox5	arachidonate 5-lipoxygenase		multiple interactions	ISO	4	152,610,283	152,657,891	RGD:6480464	CTD
G	Amy1a	amylase, alpha 1A (salivary)		multiple interactions	EXP	2	209,548,721	209,563,532	RGD:6480464	CTD
G	Arf6	ADP-ribosylation factor 6		affects localization	ISO	6	91,337,496	91,338,644	RGD:6480464	CTD
G	Arrb2	arrestin, beta 2		multiple interactions	ISO	10	57,244,071	57,284,166	RGD:6480464	CTD
G	Atp1a1	ATPase, Na+/K+ transporting, alpha 1 polypeptide		multiple interactions	EXP	2	196,657,749	196,687,242	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		decreases expression	EXP	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		increases expression	EXP	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bdkrb2	bradykinin receptor B2		multiple interactions	ISO	6	129,744,781	129,748,851	RGD:6480464	CTD
G	Calca	calcitonin-related polypeptide alpha		multiple interactions	EXP	1	172,686,168	172,691,061	RGD:6480464	CTD
G	Calca	calcitonin-related polypeptide alpha		affects activity	EXP	1	172,686,168	172,691,061	RGD:6480464	CTD
G	Calca	calcitonin-related polypeptide alpha		affects activity	EXP	1	172,686,168	172,691,061	RGD:6480464	CTD
G	Calca	calcitonin-related polypeptide alpha		affects activity	EXP	1	172,686,168	172,691,061	RGD:6480464	CTD
G	Casp3	caspase 3		increases cleavage	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		decreases expression	EXP	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		increases activity	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp7	caspase 7		increases activity	ISO	1	262,689,300	262,721,591	RGD:6480464	CTD
G	Casp9	caspase 9, apoptosis-related cysteine peptidase		increases cleavage	ISO	5	160,704,234	160,721,796	RGD:6480464	CTD
G	Ccl3	chemokine (C-C motif) ligand 3		multiple interactions	ISO	10	71,744,559	71,746,109	RGD:6480464	CTD
G	Ccl3	chemokine (C-C motif) ligand 3		multiple interactions	ISO	10	71,744,559	71,746,109	RGD:6480464	CTD
G	Col2a1	collagen, type II, alpha 1		multiple interactions	ISO	7	136,679,219	136,707,976	RGD:6480464	CTD
G	Creb1	cAMP responsive element binding protein 1		multiple interactions	EXP	9	63,170,785	63,234,727	RGD:6480464	CTD
G	Crh	corticotropin releasing hormone		multiple interactions	EXP	2	104,764,023	104,765,887	RGD:6480464	CTD
G	Crh	corticotropin releasing hormone		multiple interactions	EXP	2	104,764,023	104,765,887	RGD:6480464	CTD
G	Cyp1a1	cytochrome P450, family 1, subfamily a, polypeptide 1		increases expression	ISO	8	61,462,207	61,468,237	RGD:6480464	CTD
G	Cyp1a1	cytochrome P450, family 1, subfamily a, polypeptide 1		multiple interactions	ISO	8	61,462,207	61,468,237	RGD:6480464	CTD
G	Cyp1a1	cytochrome P450, family 1, subfamily a, polypeptide 1		multiple interactions	EXP	8	61,462,207	61,468,237	RGD:6480464	CTD
G	Cyp1a2	cytochrome P450, family 1, subfamily a, polypeptide 2		affects metabolic processing	ISO	8	61,439,062	61,447,861	RGD:6480464	CTD
G	Cyp1a2	cytochrome P450, family 1, subfamily a, polypeptide 2		multiple interactions	EXP	8	61,439,062	61,447,861	RGD:6480464	CTD
G	Cyp1a2	cytochrome P450, family 1, subfamily a, polypeptide 2		increases expression	ISO	8	61,439,062	61,447,861	RGD:6480464	CTD
G	Cyp1b1	cytochrome P450, family 1, subfamily b, polypeptide 1		multiple interactions	ISO	6	2,548,224	2,553,767	RGD:6480464	CTD
G	Cyp2c11	cytochrome P450, subfamily 2, polypeptide 11		increases oxidation	ISO	1	243,281,320	243,320,945	RGD:6480464	CTD
G	Cyp2d2	cytochrome P450, family 2, subfamily d, polypeptide 2		multiple interactions	EXP	7	120,796,210	120,800,279	RGD:6480464	CTD
G	Cyp2d3	cytochrome P450, family 2, subfamily d, polypeptide 3		affects metabolic processing	ISO	7	120,778,783	120,783,140	RGD:6480464	CTD
G	Cyp2d3	cytochrome P450, family 2, subfamily d, polypeptide 3		increases metabolic processing	ISO	7	120,778,783	120,783,140	RGD:6480464	CTD
G	Cyp2d3	cytochrome P450, family 2, subfamily d, polypeptide 3		increases oxidation	ISO	7	120,778,783	120,783,140	RGD:6480464	CTD
G	Cyp2d4	cytochrome P450, family 2, subfamily d, polypeptide 4		affects metabolic processing	ISO	7	120,742,273	120,752,274	RGD:6480464	CTD
G	Cyp2d4	cytochrome P450, family 2, subfamily d, polypeptide 4		increases metabolic processing	ISO	7	120,742,273	120,752,274	RGD:6480464	CTD
G	Cyp2d4	cytochrome P450, family 2, subfamily d, polypeptide 4		increases metabolic processing	ISO	7	120,742,273	120,752,274	RGD:6480464	CTD
G	Cyp2d4	cytochrome P450, family 2, subfamily d, polypeptide 4		increases oxidation	ISO	7	120,742,273	120,752,274	RGD:6480464	CTD
G	Cyp2d4	cytochrome P450, family 2, subfamily d, polypeptide 4		increases metabolic processing	ISO	7	120,742,273	120,752,274	RGD:6480464	CTD
G	Cyp3a2	cytochrome P450, family 3, subfamily a, polypeptide 2		increases oxidation	ISO	12	9,517,016	9,541,000	RGD:6480464	CTD
G	Egfr	epidermal growth factor receptor		multiple interactions	ISO	14	97,617,358	97,788,211	RGD:6480464	CTD
G	Egr1	early growth response 1		multiple interactions	EXP	18	27,343,919	27,346,117	RGD:6480464	CTD
G	Fas	Fas (TNF receptor superfamily, member 6)		decreases expression	EXP	1	238,259,443	238,274,745	RGD:6480464	CTD
G	Fgf1	fibroblast growth factor 1 (acidic)		increases expression	EXP	18	31,785,480	31,806,452	RGD:6480464	CTD
G	Fn1	fibronectin 1		multiple interactions	ISO	9	70,702,181	70,771,155	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		multiple interactions	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		multiple interactions	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		multiple interactions	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Gad1	glutamate decarboxylase 1		multiple interactions	EXP	3	52,789,370	52,830,038	RGD:6480464	CTD
G	Gja1	gap junction protein, alpha 1		affects localization	EXP	20	35,409,815	35,422,262	RGD:6480464	CTD
G	Gk	glycerol kinase		decreases activity	EXP	X	72,416,872	72,493,296	RGD:6480464	CTD
G	Gnas	GNAS complex locus		increases expression	EXP	3	165,213,399	165,214,551	RGD:6480464	CTD
G	Gnas	GNAS complex locus		multiple interactions	ISO	3	165,213,399	165,214,551	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		multiple interactions	ISO	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hpca	hippocalcin		affects localization	EXP	5	148,267,898	148,276,223	RGD:6480464	CTD
G	Htr1b	5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled		affects binding	EXP	8	86,700,088	86,701,248	RGD:6480464	CTD
G	Il10	interleukin 10		increases expression	EXP	13	43,953,900	43,957,766	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		multiple interactions	ISO	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		decreases secretion	EXP	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il6	interleukin 6		multiple interactions	EXP	4	456,799	461,376	RGD:6480464	CTD
G	Ins2	insulin 2		multiple interactions	ISO	1	202,935,548	202,936,379	RGD:6480464	CTD
G	Ins2	insulin 2		decreases expression	ISO	1	202,935,548	202,936,379	RGD:6480464	CTD
G	Kcne2	potassium voltage-gated channel, Isk-related family, member 2		multiple interactions	ISO	11	32,277,711	32,290,828	RGD:6480464	CTD
G	Kcnh2	potassium voltage-gated channel, subfamily H (eag-related), member 2		multiple interactions	ISO	4	6,192,644	6,224,285	RGD:6480464	CTD
G	Kcnh2	potassium voltage-gated channel, subfamily H (eag-related), member 2		decreases activity	ISO	4	6,192,644	6,224,285	RGD:6480464	CTD
G	Kcnj2	potassium inwardly-rectifying channel, subfamily J, member 2		affects response to substance	ISO	10	100,574,985	100,576,268	RGD:6480464	CTD
G	Kcnj3	potassium inwardly-rectifying channel, subfamily J, member 3		increases expression	ISO	3	37,068,672	37,256,990	RGD:6480464	CTD
G	Kcnq1	potassium voltage-gated channel, KQT-like subfamily, member 1		affects response to substance	ISO	1	203,383,401	203,803,687	RGD:6480464	CTD
G	Lep	leptin		multiple interactions	ISO	4	55,943,837	55,945,938	RGD:6480464	CTD
G	Lpl	lipoprotein lipase		multiple interactions	EXP	16	22,533,105	22,556,905	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	ISO	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	ISO	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	ISO	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	EXP	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	ISO	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	ISO	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	ISO	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	ISO	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	EXP	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	ISO	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mcl1	myeloid cell leukemia sequence 1		multiple interactions	ISO				RGD:6480464	CTD
G	Mmp2	matrix metallopeptidase 2		decreases expression	ISO	19	15,246,036	15,275,061	RGD:6480464	CTD
G	Mmp2	matrix metallopeptidase 2		decreases expression	ISO	19	15,246,036	15,275,061	RGD:6480464	CTD
G	Mmp2	matrix metallopeptidase 2		decreases secretion	ISO	19	15,246,036	15,275,061	RGD:6480464	CTD
G	Mmp9	matrix metallopeptidase 9		multiple interactions	ISO	3	155,985,473	155,993,433	RGD:6480464	CTD
G	Mmp9	matrix metallopeptidase 9		decreases expression	ISO	3	155,985,473	155,993,433	RGD:6480464	CTD
G	Mmp9	matrix metallopeptidase 9		decreases expression	ISO	3	155,985,473	155,993,433	RGD:6480464	CTD
G	Mmp9	matrix metallopeptidase 9		decreases secretion	ISO	3	155,985,473	155,993,433	RGD:6480464	CTD
G	Myh7	myosin, heavy chain 7, cardiac muscle, beta		multiple interactions	EXP	15	33,072,928	33,094,595	RGD:6480464	CTD
G	Myh7	myosin, heavy chain 7, cardiac muscle, beta		increases expression	EXP	15	33,072,928	33,094,595	RGD:6480464	CTD
G	Ngf	nerve growth factor (beta polypeptide)		multiple interactions	EXP	2	197,621,726	197,632,960	RGD:6480464	CTD
G	Ngf	nerve growth factor (beta polypeptide)		multiple interactions	EXP	2	197,621,726	197,632,960	RGD:6480464	CTD
G	Nos3	nitric oxide synthase 3, endothelial cell		affects expression	EXP	4	6,158,847	6,179,441	RGD:6480464	CTD
G	Nppa	natriuretic peptide A		multiple interactions	EXP	5	165,074,518	165,075,827	RGD:6480464	CTD
G	Nppa	natriuretic peptide A		multiple interactions	EXP	5	165,074,518	165,075,827	RGD:6480464	CTD
G	Nppa	natriuretic peptide A		increases expression	EXP	5	165,074,518	165,075,827	RGD:6480464	CTD
G	Nppa	natriuretic peptide A		affects activity	EXP	5	165,074,518	165,075,827	RGD:6480464	CTD
G	Odc1	ornithine decarboxylase 1		increases activity	ISO	6	41,309,211	41,315,796	RGD:6480464	CTD
G	Odc1	ornithine decarboxylase 1		multiple interactions	ISO	6	41,309,211	41,315,796	RGD:6480464	CTD
G	Odc1	ornithine decarboxylase 1		multiple interactions	ISO	6	41,309,211	41,315,796	RGD:6480464	CTD
G	Penk	proenkephalin		multiple interactions	EXP	5	17,509,323	17,514,265	RGD:6480464	CTD
G	Pln	phospholamban		multiple interactions	EXP	20	32,000,371	32,008,559	RGD:6480464	CTD
G	Ppargc1a	peroxisome proliferator-activated receptor gamma, coactivator 1 alpha		multiple interactions	ISO	14	64,278,115	64,370,912	RGD:6480464	CTD
G	Ppargc1a	peroxisome proliferator-activated receptor gamma, coactivator 1 alpha		decreases expression	ISO	14	64,278,115	64,370,912	RGD:6480464	CTD
G	Ppargc1a	peroxisome proliferator-activated receptor gamma, coactivator 1 alpha		multiple interactions	ISO	14	64,278,115	64,370,912	RGD:6480464	CTD
G	Prkca	protein kinase C, alpha		decreases expression	EXP	10	97,367,196	97,638,910	RGD:6480464	CTD
G	Prkcd	protein kinase C, delta		decreases expression	EXP	16	5,954,218	5,975,743	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		multiple interactions	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		multiple interactions	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		multiple interactions	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		decreases expression	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		multiple interactions	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		decreases expression	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ren	renin		multiple interactions	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		multiple interactions	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		multiple interactions	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		multiple interactions	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		decreases activity	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		decreases expression	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		multiple interactions	EXP	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		multiple interactions	EXP	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		multiple interactions	EXP	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		decreases activity	EXP	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		decreases activity	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		decreases expression	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		decreases activity	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		decreases activity	EXP	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		decreases activity	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		decreases activity	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		decreases activity	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		decreases activity	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Rps6kb1	ribosomal protein S6 kinase, polypeptide 1		increases phosphorylation	ISO	10	76,657,024	76,698,088	RGD:6480464	CTD
G	Rps6kb1	ribosomal protein S6 kinase, polypeptide 1		multiple interactions	ISO	10	76,657,024	76,698,088	RGD:6480464	CTD
G	Scnn1a	sodium channel, nonvoltage-gated 1 alpha		multiple interactions	EXP	4	161,445,936	161,469,267	RGD:6480464	CTD
G	Slc22a1	solute carrier family 22 (organic cation transporter), member 1		multiple interactions	ISO	1	42,351,239	42,378,295	RGD:6480464	CTD
G	Slc22a2	solute carrier family 22 (organic cation transporter), member 2		multiple interactions	ISO	1	42,395,676	42,442,847	RGD:6480464	CTD
G	Slc22a3	solute carrier family 22 (extraneuronal monoamine transporter), member 3		multiple interactions	ISO	1	42,690,158	42,781,895	RGD:6480464	CTD
G	Slc22a5	solute carrier family 22 (organic cation/carnitine transporter), member 5		multiple interactions	ISO	10	39,311,729	39,338,718	RGD:6480464	CTD
G	Slc8a1	solute carrier family 8 (sodium/calcium exchanger), member 1		multiple interactions	ISO	6	4,421,046	4,691,716	RGD:6480464	CTD
G	Stat3	signal transducer and activator of transcription 3 (acute-phase response factor)		multiple interactions	ISO	10	89,821,078	89,872,970	RGD:6480464	CTD
G	Stat3	signal transducer and activator of transcription 3 (acute-phase response factor)		multiple interactions	ISO	10	89,821,078	89,872,970	RGD:6480464	CTD
G	Sts	steroid sulfatase (microsomal), isozyme S		multiple interactions	ISO	X	63,915,803	63,923,834	RGD:6480464	CTD
G	Thy1	Thy-1 cell surface antigen		multiple interactions	ISO	8	47,027,721	47,031,857	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		increases expression	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Ugt2b	UDP glycosyltransferase 2 family, polypeptide B		increases glucuronidation	EXP	14	22,154,370	22,178,222	RGD:6480464	CTD
G	Vegfa	vascular endothelial growth factor A		decreases expression	ISO	9	10,520,730	10,536,071	RGD:6480464	CTD
G	Vegfa	vascular endothelial growth factor A		multiple interactions	ISO	9	10,520,730	10,536,071	RGD:6480464	CTD

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	492574
role	482262
biological role	480454
aetiopathogenetic role	109798
neurotoxin	82102
ammonia	74849
organic amino compound	74788
secondary amino compound	4472
(-)-demecolcine	6
(1S,2R)-5-methoxy-1-methyl-2-(propylamino)tetralin	2
(2R,3S,2'R)-nadolol +	5
(2R,3S,2'S)-nadolol +	5
(2S,3R,2'R)-nadolol +	5
(2S,3R,2'S)-nadolol +	5
2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol] +	37
2,6-dihydroxypseudooxynicotine	0
2-(hydroxymethyl)-4-(1-hydroxy-2-\{[6-(4-phenylbutoxy)hexyl]amino\}ethyl)phenol +	35
3-\{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl\}propanoic acid +	0
4-(methylamino)antipyrine	0
5-[(1-phenylcyclohexyl)amino]pentanoic acid	0
6-hydroxypseudooxynicotine	0
CGP 12177	0
CGP 78608	0
ICI 118551	0
L-BMAA	0
N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine	0
N-[2-hydroxy-5-(1-hydroxy-2-\{[1-(4-methoxyphenyl)propan-2-yl]amino\}ethyl)phenyl]formamide +	27
N-ethylasparagine +	0
N-methyl-1-(5-pyridin-3-ylfuran-2-yl)methanamine	0
N-methylglucamine +	12
TMC-52A	0
TMC-52B	0
TMC-52C	0
TMC-52D	0